title: Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.
abstract: Binding proteins for insulin-like growth factors (IGFs) IGF-I and IGF-II, known as IGFBPs, control the distribution, function and activity of IGFs in various cell tissues and body fluids. Insulin-like growth factor-binding protein-5 (IGFBP-5) is known to modulate the stimulatory effects of IGFs and is the major IGF-binding protein in bone tissue. We have expressed two N-terminal fragments of IGFBP-5 in Escherichia coli; the first encodes the N-terminal domain of the protein (residues 1-104) and the second, mini-IGFBP-5, comprises residues Ala40 to Ile92. We show that the entire IGFBP-5 protein contains only one high-affinity binding site for IGFs, located in mini-IGFBP-5. The solution structure of mini-IGFBP-5, determined by nuclear magnetic resonance spectroscopy, discloses a rigid, globular structure that consists of a centrally located three-stranded anti-parallel beta-sheet. Its scaffold is stabilized further by two inside packed disulfide bridges. The binding to IGFs, which is in the nanomolar range, involves conserved Leu and Val residues localized in a hydrophobic patch on the surface of the IGFBP-5 protein. Remarkably, the IGF-I receptor binding assays of IGFBP-5 showed that IGFBP-5 inhibits the binding of IGFs to the IGF-I receptor, resulting in reduction of receptor stimulation and autophosphorylation. Compared with the full-length IGFBP-5, the smaller N-terminal fragments were less efficient inhibitors of the IGF-I receptor binding of IGFs.
authors.affiliation: Max Planck Institute for Biochemistry, D-82152 Martinsried.
authors.forename: W
authors.initials: W
authors.lastname: Kalus
authors.forename: M
authors.initials: M
authors.lastname: Zweckstetter
authors.forename: C
authors.initials: C
authors.lastname: Renner
authors.forename: Y
authors.initials: Y
authors.lastname: Sanchez
authors.forename: J
authors.initials: J
authors.lastname: Georgescu
authors.forename: M
authors.initials: M
authors.lastname: Grol
authors.forename: D
authors.initials: D
authors.lastname: Demuth
authors.forename: R
authors.initials: R
authors.lastname: Schumacher
authors.forename: C
authors.initials: C
authors.lastname: Dony
authors.forename: K
authors.initials: K
authors.lastname: Lang
authors.forename: T A
authors.initials: TA
authors.lastname: Holak
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D017931:DNA Primers; D006801:Humans; D006868:Hydrolysis; D018975:Insulin-Like Growth Factor Binding Protein 5 / Q000737:chemistry / Q000378:metabolism*; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D017451:Receptors, Somatomedin / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D013002:Somatomedins / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D018975:Insulin-Like Growth Factor Binding Protein 5; D010446:Peptide Fragments; D017451:Receptors, Somatomedin; D011994:Recombinant Proteins; D013002:Somatomedins